Dendritic cells in pancreatic cancer immunotherapy: Vaccines and combination immunotherapies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dendritic cells in pancreatic cancer immunotherapy: Vaccines and combination immunotherapies

Published:2019-12 Issue:12 Volume:215 Page:152691
ISSN:0344-0338
Container-title:Pathology - Research and Practice
language:en
Short-container-title:Pathology - Research and Practice

Author:

Yang Jia,Shangguan Junjie,Eresen Aydin,Li Yu,Wang Jian,Zhang Zhuoli

Funder

National Cancer Institute

key research and development program of Tianjin Municipal Science and Technology Commission

Publisher

Elsevier BV

Subject

Cell Biology,Pathology and Forensic Medicine

Reference101 articles.

1. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States;Rahib;Cancer Res.,2014

2. Cancer statistics;Siegel;CA Cancer J. Clin.,2019

3. Long-term survival after curative resection for pancreatic ductal adenocarcinoma: clinicopathologic analysis of 5-Year survivors;Conlon;Ann. Surg.,1996

4. Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy;Varadhachary;Ann. Surg. Oncol.,2006

5. The cancer vaccine roller coaster;Goldman;Nat. Biotechnol.,2009

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential impact of epithelial splicing regulatory protein 1 (ESRP1) associated with tumor immunity in pancreatic adenocarcinoma;Journal of Proteomics;2024-09

2. TNFR1 signaling promotes pancreatic tumor growth by limiting dendritic cell number and function;Cell Reports Medicine;2024-08

3. Frontiers and future of immunotherapy for pancreatic cancer: from molecular mechanisms to clinical application;Frontiers in Immunology;2024-05-02

4. Unlocking the Potential of Induced Pluripotent Stem Cells in Revolutionizing Cancer Therapy;Current Stem Cell Research & Therapy;2024-04-15

5. Bioinformatics-based analysis of the relationship between disulfidptosis and prognosis and treatment response in pancreatic cancer;Scientific Reports;2023-12-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3